Bone marrow runs the (bone) show
Open Access
- 27 October 2021
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 218 (12)
- https://doi.org/10.1084/jem.20211996
Abstract
In this issue of JEM, a paper by Kim et al. (2021. J. Exp. Med. https://doi.org/10.1084/jem.20211872), asking a simple question through a remarkable alliance of human and mouse genetics, demonstrates that a prevalent hematological condition can lead to osteoporosis. This work is important by virtue of the quality of its results and its implication for the relationship between bone and its marrow.This publication has 14 references indexed in Scilit:
- Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in miceScience, 2017
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromesBlood, 2015
- Leukaemogenesis induced by an activating β-catenin mutation in osteoblastsNature, 2014
- Anti–IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone lossThe Journal of Experimental Medicine, 2011
- Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and DiseaseAnnual Review of Immunology, 2011
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemiaNature, 2010
- Convergence between bone and energy homeostases: Leptin regulation of bone massCell Metabolism, 2006
- Osteoblastic cells regulate the haematopoietic stem cell nicheNature, 2003
- Reaching a Genetic and Molecular Understanding of Skeletal DevelopmentDevelopmental Cell, 2002
- Letter to the editorCalcified Tissue International, 1982